Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aspen Aerogels (ASPN) Short-term Investments (2022 - 2025)

Historic Short-term Investments for Aspen Aerogels (ASPN) over the last 5 years, with Q3 2025 value amounting to $1.7 million.

  • Aspen Aerogels' Short-term Investments rose 32750.0% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 million, marking a year-over-year increase of 32750.0%. This contributed to the annual value of $394000.0 for FY2024, which is 5887.1% up from last year.
  • Per Aspen Aerogels' latest filing, its Short-term Investments stood at $1.7 million for Q3 2025, which was up 32750.0% from $410000.0 recorded in Q2 2025.
  • Aspen Aerogels' 5-year Short-term Investments high stood at $1.7 million for Q3 2025, and its period low was $200000.0 during Q1 2024.
  • Moreover, its 4-year median value for Short-term Investments was $400000.0 (2024), whereas its average is $554750.0.
  • As far as peak fluctuations go, Aspen Aerogels' Short-term Investments tumbled by 7977.16% in 2023, and later skyrocketed by 32750.0% in 2025.
  • Quarter analysis of 4 years shows Aspen Aerogels' Short-term Investments stood at $1.2 million in 2022, then crashed by 79.77% to $248000.0 in 2023, then surged by 58.87% to $394000.0 in 2024, then surged by 334.01% to $1.7 million in 2025.
  • Its Short-term Investments stands at $1.7 million for Q3 2025, versus $410000.0 for Q2 2025 and $400000.0 for Q1 2025.